Novo Nordisk and Aspect Deepen Cell Therapy Alliance in Diabetes
Novo Nordisk and Aspect Biosystems have announced the expansion of their strategic partnership, entering a new phase focused on developing advanced cellular medicines for diabetes that…
Read More...
Read More...
